Julie A. Wolfram

503 total citations
13 papers, 392 citations indexed

About

Julie A. Wolfram is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Julie A. Wolfram has authored 13 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Julie A. Wolfram's work include Cardiomyopathy and Myosin Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). Julie A. Wolfram is often cited by papers focused on Cardiomyopathy and Myosin Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). Julie A. Wolfram collaborates with scholars based in United States, Japan and Brazil. Julie A. Wolfram's co-authors include J. Kevin Donahue, Nicole L. Ward, Doina Diaconu, Thomas S. McCormick, Candace M. Loyd, Hyoung‐gon Lee, Denise A. Hatala, Mark A. Smith, Brian D. Hoit and Anita C. Gilliam and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and British Journal of Dermatology.

In The Last Decade

Julie A. Wolfram

13 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. Wolfram United States 12 194 114 86 62 51 13 392
Silvia Cardarelli Italy 12 226 1.2× 78 0.7× 28 0.3× 18 0.3× 38 0.7× 43 466
Takayuki Sato Japan 13 142 0.7× 74 0.6× 50 0.6× 53 0.9× 7 0.1× 20 384
Yoshitaka Horikawa Japan 9 166 0.9× 64 0.6× 24 0.3× 55 0.9× 20 0.4× 15 507
Kim K. Creus Belgium 11 192 1.0× 58 0.5× 18 0.2× 43 0.7× 32 0.6× 15 368
Eneda Hoxha United States 7 244 1.3× 64 0.6× 136 1.6× 29 0.5× 8 0.2× 11 426
T Kumamoto Japan 10 156 0.8× 73 0.6× 37 0.4× 76 1.2× 14 0.3× 24 371
Haritz Irizar Spain 12 243 1.3× 108 0.9× 19 0.2× 56 0.9× 17 0.3× 21 500
Valerie M. Harris United States 7 86 0.4× 57 0.5× 66 0.8× 57 0.9× 8 0.2× 8 319
Takeshi Kiyoi Japan 13 165 0.9× 78 0.7× 14 0.2× 40 0.6× 15 0.3× 38 363
Hisashi Kanemaru Japan 11 304 1.6× 135 1.2× 25 0.3× 36 0.6× 60 1.2× 39 562

Countries citing papers authored by Julie A. Wolfram

Since Specialization
Citations

This map shows the geographic impact of Julie A. Wolfram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Wolfram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Wolfram more than expected).

Fields of papers citing papers by Julie A. Wolfram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Wolfram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Wolfram. The network helps show where Julie A. Wolfram may publish in the future.

Co-authorship network of co-authors of Julie A. Wolfram

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Wolfram. A scholar is included among the top collaborators of Julie A. Wolfram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Wolfram. Julie A. Wolfram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liu, Zhao, J. Emanuel Finet, Julie A. Wolfram, et al.. (2019). Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure. Heart Rhythm. 16(7). 1080–1088. 39 indexed citations
2.
Willis, Monte S., Darcy Holley, Zhongjing Wang, et al.. (2017). BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. Journal of Molecular and Cellular Cardiology. 105. 99–109. 17 indexed citations
3.
Smith, Andrew L., et al.. (2017). Impact of Insurance Precertification on Discharge of Stroke Patients to Acute Rehabilitation or Skilled Nursing Facility. Journal of Stroke and Cerebrovascular Diseases. 26(4). 711–716. 14 indexed citations
4.
Siedlak, Sandra L., Julie A. Wolfram, Akihiko Nunomura, et al.. (2014). Accumulation of Intraneuronal Amyloid-β is Common in Normal Brain. Current Alzheimer Research. 11(4). 317–324. 15 indexed citations
5.
Wolfram, Julie A. & J. Kevin Donahue. (2013). Gene Therapy to Treat Cardiovascular Disease. Journal of the American Heart Association. 2(4). e000119–e000119. 50 indexed citations
6.
Loyd, Candace M., Doina Diaconu, Wen Fu, et al.. (2012). Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions.. PubMed. 5(1). 1–11. 12 indexed citations
7.
Wolfram, Julie A., Anna Liner, Xiongwei Zhu, et al.. (2011). The role of E2F1 in the development of hypertrophic cardiomyopathy.. PubMed. 4(5). 521–5. 8 indexed citations
8.
Ward, Nicole L., et al.. (2010). Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit. Journal of Dermatological Science. 61(1). 14–22. 13 indexed citations
9.
Wolfram, Julie A., Edward J. Lesnefsky, Brian D. Hoit, Mark A. Smith, & Hyoung‐gon Lee. (2010). Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy. Therapeutic Advances in Chronic Disease. 2(2). 133–144. 20 indexed citations
10.
Ward, Nicole L., et al.. (2010). Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice. British Journal of Dermatology. 164(4). 750–758. 64 indexed citations
11.
Wikenheiser, Jamie C., Julie A. Wolfram, Madhusudhana Gargesha, et al.. (2009). Altered hypoxia‐inducible factor‐1 alpha expression levels correlate with coronary vessel anomalies. Developmental Dynamics. 238(10). 2688–2700. 31 indexed citations
12.
Wolfram, Julie A., Doina Diaconu, Denise A. Hatala, et al.. (2009). Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of Psoriasis. American Journal Of Pathology. 174(4). 1443–1458. 70 indexed citations
13.
Lee, Hyoung‐gon, Qun Chen, Julie A. Wolfram, et al.. (2009). Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure. PLoS ONE. 4(9). e7172–e7172. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026